Nautilus Biotechnology annual operating expenses
2020
2021
2022
2023
2024
2025
Nautilus Biotechnology Operating Expenses Growth & History (NAUT)
Nautilus Biotechnology's operating expenses was $66.8M for fiscal 2025.
View full Nautilus Biotechnology company overviewNautilus Biotechnology annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $66.8M | −$14.6M | −17.97% |
| 2024 | 2024-12-31 | $81.5M | $5.3M | +6.99% |
| 2023 | 2023-12-31 | $76.2M | $12.5M | +19.70% |
| 2022 | 2022-12-31 | $63.6M | $13.1M | +25.98% |
| 2021 | 2021-12-31 | $50.5M | $34.8M | +220.74% |
| 2020 | 2020-12-31 | $15.7M | — | — |
Nautilus Biotechnology quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $15.8M | −$1.3M | −7.83% |
| Q1 2026 | 2026-03-31 | $16.1M | −$2.7M | −14.43% |
| Q4 2025 | 2025-12-31 | $15.4M | −$4.6M | −22.80% |
| Q3 2025 | 2025-09-30 | $15.5M | −$3.6M | −18.99% |
| Q2 2025 | 2025-06-30 | $17.1M | −$3.7M | −17.76% |
| Q1 2025 | 2025-03-31 | $18.8M | −$2.8M | −12.79% |
| Q4 2024 | 2024-12-31 | $20.0M | −$21,000 | −0.10% |
| Q3 2024 | 2024-09-30 | $19.1M | $25,000 | +0.13% |
| Q2 2024 | 2024-06-30 | $20.8M | $1.8M | +9.32% |
| Q1 2024 | 2024-03-31 | $21.6M | $3.5M | +19.64% |
| Q4 2023 | 2023-12-31 | $20.0M | $3.7M | +22.68% |
| Q3 2023 | 2023-09-30 | $19.1M | $3.3M | +20.58% |
| Q2 2023 | 2023-06-30 | $19.0M | $3.5M | +22.91% |
| Q1 2023 | 2023-03-31 | $18.1M | $2.0M | +12.72% |
| Q4 2022 | 2022-12-31 | $16.3M | −$512,000 | −3.04% |
| Q3 2022 | 2022-09-30 | $15.8M | $1.3M | +8.59% |
| Q2 2022 | 2022-06-30 | $15.5M | $4.8M | +44.64% |
| Q1 2022 | 2022-03-31 | $16.0M | $7.6M | +90.35% |
| Q4 2021 | 2021-12-31 | $16.8M | — | — |
| Q3 2021 | 2021-09-30 | $14.6M | $10.5M | +261.76% |
| Q2 2021 | 2021-06-30 | $10.7M | $7.3M | +214.62% |
| Q1 2021 | 2021-03-31 | $8.4M | — | — |
| Q3 2020 | 2020-09-30 | $4.0M | — | — |
| Q2 2020 | 2020-06-30 | $3.4M | — | — |
Nautilus Biotechnology operating expenses trends
Over the last five fiscal years, Nautilus Biotechnology's operating expenses increased from $15.7M to $66.8M, a change of $51.1M. The latest reported quarter, Q2 2026, shows $15.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nautilus Biotechnology source filings ↗